139 related articles for article (PubMed ID: 26770520)
1. Therapeutic efficacy of brucea javanica oil emulsion (BJOE) combined with transcatheter hepatic arterial chemoembolization (TACE) in patients with primary liver cancer.
Jin W; Han H; Zhou S; Wang Y; Dong T; Zhao C
Int J Clin Exp Med; 2015; 8(10):18954-62. PubMed ID: 26770520
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice.
Huang YF; Zhou JT; Qu C; Dou YX; Huang QH; Lin ZX; Xian YF; Xie JH; Xie YL; Lai XP; Su ZR
J Ethnopharmacol; 2017 Feb; 198():389-398. PubMed ID: 28119098
[TBL] [Abstract][Full Text] [Related]
3.
Qiu ZH; Zhang WW; Zhang HH; Jiao GH
World J Gastroenterol; 2019 May; 25(20):2463-2472. PubMed ID: 31171890
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of therapeutic effects between transcatheter arterial chemoembolization and transcatheter arterial-portal venous double chemoembolization in treatment of moderate and advanced stages of primary liver carcinoma].
Wu YP; Zhang WZ; Li L; Guo RP; Xie CM; Cai PQ
Ai Zheng; 2003 Aug; 22(8):880-3. PubMed ID: 12917041
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of Brucea javanica oil emulsion on experimental Crohn's disease in rats: Involvement of TLR4/ NF-κB signaling pathway.
Huang YF; Li QP; Dou YX; Wang TT; Qu C; Liang JL; Lin ZX; Huang XQ; Su ZR; Chen JN; Xie YL
Biomed Pharmacother; 2019 Jun; 114():108766. PubMed ID: 30901719
[TBL] [Abstract][Full Text] [Related]
6. Involvement of autophagy inhibition in
Yan Z; Zhang B; Huang Y; Qiu H; Chen P; Guo GF
Oncol Lett; 2015 Mar; 9(3):1425-1431. PubMed ID: 25663926
[No Abstract] [Full Text] [Related]
7. Evaluation of efficacy and safety for Brucea javanica oil emulsion in the control of the malignant pleural effusions via thoracic perfusion.
Fuhong D; Xiang G; Haiying L; Jiangye W; Xueming G; Wenxiao C
BMC Cancer; 2018 Apr; 18(1):411. PubMed ID: 29649989
[TBL] [Abstract][Full Text] [Related]
8. Brucea javanica oil emulsion significantly improved the effect of anti-programmed cell death protein-1 immunotherapy.
Meng J; Yu Z; Chen H; Yu X; Jiang M; Zeng XA; You J
Phytomedicine; 2022 Dec; 107():154446. PubMed ID: 36182799
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significances of serum soluble fas and soluble fas ligand in chronic hepatitis B].
Jun EJ; Han JY; Sun HS
Korean J Hepatol; 2006 Dec; 12(4):507-14. PubMed ID: 17237628
[TBL] [Abstract][Full Text] [Related]
10. [Effects of Brucea javanica oil emulsion on human papilloma virus type 16 infected cells and mechanisms research].
Hu Y; Wan XJ; Pan LL; Zhang SH; Zheng FY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov; 33(11):1545-51. PubMed ID: 24483118
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of a combination of soluble Fas and soluble Fas ligand in the serum of patients with Ta bladder cancer.
Mizutani Y; Yoshida O; Ukimura O; Kawauchi A; Bonavida B; Miki T
Cancer Biother Radiopharm; 2002 Oct; 17(5):563-7. PubMed ID: 12470426
[TBL] [Abstract][Full Text] [Related]
12.
Pan P; Yang BX; Ge XL
Oncol Lett; 2018 Mar; 15(3):3870-3875. PubMed ID: 29456736
[No Abstract] [Full Text] [Related]
13. Brucea javanica oil emulsion alleviates cachexia induced by Lewis lung cancer cells in mice.
Chen C; Wang B
J Drug Target; 2018 Mar; 26(3):222-230. PubMed ID: 28701059
[TBL] [Abstract][Full Text] [Related]
14.
Wang Y; Chen B; Xiao M; Wang X; Peng Y
Front Pharmacol; 2022; 13():935155. PubMed ID: 35959437
[No Abstract] [Full Text] [Related]
15. Comparison of the effects of postoperative prophylactic transcatheter arterial chemoembolization (TACE) and transhepatic arterial infusion (TAI) after hepatectomy for primary liver cancer.
Chen J; Zhang Y; Cai H; Yang Y; Fei Duan Y
J BUON; 2018; 23(3):629-634. PubMed ID: 30003729
[TBL] [Abstract][Full Text] [Related]
16. The Promotional Effect of Hollow MnO
Hu Q; Zhang S; Zhu J; Yin L; Liu S; Huang X; Ke G
Biomed Res Int; 2021; 2021():6631533. PubMed ID: 33816622
[TBL] [Abstract][Full Text] [Related]
17. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
[TBL] [Abstract][Full Text] [Related]
18. [Change in serum levels of soluble Fas and soluble FasL in patients with multiple organ dysfunction syndrome].
Fu Y; Xiao QM; Wang T; Chen XH; Ai YH
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Nov; 18(11):691-4. PubMed ID: 17092425
[TBL] [Abstract][Full Text] [Related]
19. [Levels and clinic significance of serum soluble Fas and soluble Fas ligand in coal workers' pneumoconiosis].
Yuan BJ; Liu ZZ; Ding XR; Zou JM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Feb; 24(2):96-8. PubMed ID: 16600114
[TBL] [Abstract][Full Text] [Related]
20.
Ye L; Zhao JF; Wang YM; Chen WH; Qian S; Zhou ZG; Xu M
Transl Cancer Res; 2020 Feb; 9(2):918-929. PubMed ID: 35117437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
